BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18612136)

  • 1. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Gail MH
    J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
    Gail MH
    J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
    Dite GS; Mahmoodi M; Bickerstaffe A; Hammet F; Macinnis RJ; Tsimiklis H; Dowty JG; Apicella C; Phillips KA; Giles GG; Southey MC; Hopper JL
    Breast Cancer Res Treat; 2013 Jun; 139(3):887-96. PubMed ID: 23774992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Spitz MR; Amos CI; D'Amelio A; Dong Q; Etzel C
    J Natl Cancer Inst; 2009 Dec; 101(24):1731-2; author reply 1732. PubMed ID: 19903803
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.
    Dai J; Hu Z; Jiang Y; Shen H; Dong J; Ma H; Shen H
    Breast Cancer Res; 2012 Jan; 14(1):R17. PubMed ID: 22269215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    Banegas MP; John EM; Slattery ML; Gomez SL; Yu M; LaCroix AZ; Pee D; Chlebowski RT; Hines LM; Thompson CA; Gail MH
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28003316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
    Milne RL; Gaudet MM; Spurdle AB; Fasching PA; Couch FJ; Benítez J; Arias Pérez JI; Zamora MP; Malats N; Dos Santos Silva I; Gibson LJ; Fletcher O; Johnson N; Anton-Culver H; Ziogas A; Figueroa J; Brinton L; Sherman ME; Lissowska J; Hopper JL; Dite GS; Apicella C; Southey MC; Sigurdson AJ; Linet MS; Schonfeld SJ; Freedman DM; Mannermaa A; Kosma VM; Kataja V; Auvinen P; Andrulis IL; Glendon G; Knight JA; Weerasooriya N; Cox A; Reed MW; Cross SS; Dunning AM; Ahmed S; Shah M; Brauch H; Ko YD; Brüning T; ; Lambrechts D; Reumers J; Smeets A; Wang-Gohrke S; Hall P; Czene K; Liu J; Irwanto AK; Chenevix-Trench G; Holland H; ; ; Giles GG; Baglietto L; Severi G; Bojensen SE; Nordestgaard BG; Flyger H; John EM; West DW; Whittemore AS; Vachon C; Olson JE; Fredericksen Z; Kosel M; Hein R; Vrieling A; Flesch-Janys D; Heinz J; Beckmann MW; Heusinger K; Ekici AB; Haeberle L; Humphreys MK; Morrison J; Easton DF; Pharoah PD; García-Closas M; Goode EL; Chang-Claude J
    Breast Cancer Res; 2010; 12(6):R110. PubMed ID: 21194473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
    Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
    BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.
    Rinella ES; Shao Y; Yackowski L; Pramanik S; Oratz R; Schnabel F; Guha S; LeDuc C; Campbell CL; Klugman SD; Terry MB; Senie RT; Andrulis IL; Daly M; John EM; Roses D; Chung WK; Ostrer H
    Hum Genet; 2013 May; 132(5):523-36. PubMed ID: 23354978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
    Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
    Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.
    Park JH; Gail MH; Greene MH; Chatterjee N
    J Clin Oncol; 2012 Jun; 30(17):2157-62. PubMed ID: 22585702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
    Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
    J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating breast cancer risk projections for Hispanic women.
    Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
    Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.
    Tapper W; Hammond V; Gerty S; Ennis S; Simmonds P; Collins A; ; Eccles D
    Breast Cancer Res; 2008; 10(6):R108. PubMed ID: 19094228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population.
    Sueta A; Ito H; Kawase T; Hirose K; Hosono S; Yatabe Y; Tajima K; Tanaka H; Iwata H; Iwase H; Matsuo K
    Breast Cancer Res Treat; 2012 Apr; 132(2):711-21. PubMed ID: 22160591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.